From Fear to Confidence: DecisionDx-Melanoma. Greg’s Story of Empowerment Over a Melanoma Diagnosis
Discover Greg’s inspiring journey from a cancer diagnosis to a life of outdoor adventures, empowered by the DecisionDx-Melanoma test. Follow his path to knowledge and resilience in the face of melanoma.
Be Your Own Advocate: Morgan England, Stage III Melanoma Survivor, Shares Her Story
As a Stage III Melanoma survivor, Morgan speaks on how important it is to be your own advocate. After her diagnosis, she requested the DecisionDx-Melanoma test from her doctor for the additional information it can provide. The results she received from her DecisionDx-Melanoma test report continue to help reduce her anxiety and provide confidence about her future.
DecisionDx®-Melanoma Helps to Guide Patient Management Decisions
Dr. Aaron Farberg speaks about how the DecisionDx-Melanoma test results helps better identify a patient's risk of metastasis and how some patients may be able to forgo a SLNB procedure.
DecisionDx®-Melanoma Increases the Risk Prediction that is Currently Available for Patients
Dr. Clay Cockerell speaks on how the DecisionDx-Melanoma test is not intended to replace staging systems but how using GEP can increase risk prediction for patients with Stage I-III melanoma.
Molecular Prognostic Tests are Changing Management of Dermatologic Cancers
Learn more about how Gene Expression Profiling (GEP) can be used to individualize patient care and management of melanoma.
More Accurately Predicting Individual Risk of Recurrence or Metastasis
DecisionDx- Melanoma can be used to determine what level of follow-up, imaging, and referrals are appropriate for individual patients.
SLNB Surgical Procedures: Improving Patient Selection
DecisionDx-Melanoma can guide the decision of whether to perform or forgo a sentinel lymph node biopsy.
The Limitations of Traditional Approaches
Using staging systems alone may miss patients with aggressive tumor biology. Listen in, to learn how DecisionDx-Melanoma addresses these limitations by improving prognostic accuracy.